Emerson Exchange 365
Blogs
    • 24 Mar 2017

    Automating Bioprocess Single-Use Systems

    For those not in the pharmaceutical and biotech manufacturing industries, if you ever visit one of these facilities you’ll be struck by the clean, shiny stainless steel vessels and piping. Given the importance of hygiene in the production of medicines, most processes include clean-in-place (CIP) and sterilize-in-place operations (SIP). The capital costs and ongoing time requirements for this stainless-steel equipment...
    • 14 Mar 2017

    Capital Project Efficiency-Operational Flexibility-Product Lifecycle Efficiency at Interphex

    Author: Michalle Adkins At the March 21-23 Interphex 2017 , Emerson exhibitor staff will be discussing three main themes: delivering capital projects on time with lower risk; comprehensive automation solutions for flexible, single-use facilities; and improving efficiency across the product lifecycle. Life Sciences companies are expanding globally in order to provide life-saving or life-enhancing solutions to more...
    • 26 Jan 2017

    Best Practices Specifying MES Workflows for Life Sciences Projects

    Author: Jonathan Lustri Manufacturing Execution System (MES) Life Sciences projects can be costly and be a challenge to keep in control. The biggest contributor to these challenges are the defining and design of manufacturing workflows. A Workflow is an MES procedural object used to replace the paper batch record. And for greenfield projects in particular, this can be a challenge. In order to define best practices...
    • 10 Jan 2017

    Measurement Repeatability in CIP and SIP Operations

    One only has to do a Google image search on pharmaceutical equipment to see the clean, sanitary conditions required for pharmaceutical and biopharmaceutical processing. The measurement instrumentation must be able to handle the tough conditions when cleaning and sanitization operations are performed. In a Pharmaceutical Manufacturing article, Ensuring Batch-to-Batch Repeatability in Sanitary Processes , Emerson’s...
    • 10 Nov 2016

    Pharmaceutical and Biotech Manufacturing Data Integrity

    The integrity of the data behind the production of pharmaceutical products is paramount. In recent years, the U.S. Food & Drug Administration (FDA) has increasingly observed data integrity related Current Good Manufacturing Practices (CGMP) violations during CGMP inspections. At the recent Emerson Exchange conference, Emerson’s Michalle Adkins co-moderated the Life Sciences Industry Forum session with experts...
    • 13 Oct 2016

    Pharmaceutical and Biotech Automation Knowledge Exchange

    The pharmaceutical and biopharmaceutical industries have been interpreting recent FDA draft guidance— Data Integrity and Compliance With CGMP Guidance —and exploring new areas such as continuous manufacturing. The Emerson Life Sciences team has a full program of forums, workshops and short courses available for manufacturers in the Life Sciences industries at to October 24-28 Emerson Exchange conference in Austin. ...
    • 17 Aug 2016

    Integrating Single Use Equipment More Easily with Control and Manufacturing Execution Systems

    One of the trends in the biopharmaceutical industries that have taken root over the past decade and a half is the use of single-use, disposable equipment in the manufacturing process. Prior to their use, these facilities relied on inflexible, hard-piped equipment. An American Pharmaceutical Review article highlights the benefits of single-use equipment: Single-use disposable devices and systems have reduced overall...
    • 4 Aug 2016

    Integrated Biometric Authentication in Electronic Records

    How many of you have more passwords than you can possibly remember? Count me in with the affirmatives. Biometric authentication is one way to overcome this large and growing problem. For process manufacturers and producers, especially those in highly...
    • 23 Jun 2016

    Trends in the Life Sciences Industry

    For pharmaceutical and biotech manufacturers, trends in the market place are driving changes in the way they have historically operated their production processes. I caught up with Emerson’s Michalle Adkins who shared these trends with me. She ...
    • 28 Apr 2016

    FDA Guidance for Data Integrity and Compliance

    Author: Michalle Adkins In April 2016, the FDA issued Data Integrity and Compliance With CGMP Guidance for Industry . This is on the heels of a lot of related 483s, warning letters , and more severe actions with respect to this issue. There are some ...